LIVE CLIPS
Episode 10-29-2025
If the general goal is like, let's build a fab in America, I can imagine a bunch of different ways to solve that. But how did you go about solving it? Yeah. So up to now, the company is really three years old and the big thrust so far has been building lithography tools, demonstrating that they work, printing the smallest things that humans are able to go and print. And that's been the focus really up to now. And in terms of like, what kind of tool the IP and the like, our focus has been how do you reduce cost and complexity. And so all of the design choices we've made have been driven by that. And really like EUV and the tools that, that exist today, these are modern miracles. Yeah, these things are incredible. The engineering, incredible. Yeah, but, but, but the choices were made in the, in the, really the 90s and took a while to scale up. Our approach has been on the lithography side. If you were building a next generation lithography tool today, would you make the same technical choices we've believed? No. And the answer is no. What's it been like on the recruiting side? Have you been visiting the Netherlands?
Only be able to achieve be achieved across decades. Right. This is not the kind of company you start and expect to, you know it's a massive journey but like how do you break it up with the team? Like what are you looking to accomplish more specifically in the next like one to two years? Well moving quickly I think is sort of one of the key important parts of this. I think that this team 10 years from now is far less important for the United States 2, 3, 4 from now. And so our goal is in 2028 to actually have a facility constructed and be running wafers. And so one of the reasons why we're coming out publicly is it's going to be very hard to start building big particle accelerators, big clean rooms in secret. And so the goal is we start doing that very quickly and sprint to. 28, walk through some of the milestones to date. Do you have to come up with new.
What you're building and where it's positioned in the. In the supply chain of the semiconductor industry. Sure. I think, quite simply, what we're. What we're doing is a bet that America can do hard things again. Yeah. And that if it's important enough, then we can go and do it. It's not a question of whether we can or not. And I think when it comes to advanced chips, I think we all know and we all believe this is certainly important enough. And so our. Our bet is that the United States invented this technology, we can invent the next generation again. And starting with the core process of lithography is how you can actually go and make what we think a next generation foundry. Yep. Okay. So I think many viewers will be familiar with the general semiconductor stack. You have the.
And fine tune models with serverless GPUs and on demand clusters. Toby Lutke was taking shots at AI note takers. He hit the timeline and said having some AI follow you into your Zoom meetings or Google Meet for taking notes is the digital equivalent of showing up to a meeting with your fly down. What do you think your anti AI, you're anti Clanker in the group chat. I never let, I never let him in. You never let him in. You never let him sit there in the Zoom room. The Clanker. The Clanker is in the waiting room. It's ready to be let in. Oh, I forgot. Sorry. This, this, this reply post is Firefly is waiting in the lobby and that's where Firefly will stay. Toby's on fire. He said Firefly better fly right into the. In the E O D D A M N Fire. Yeah. So I don't know. He didn't elaborate on why he doesn't like this friend of the show TJ Parker said maybe it has something to do with the fact that if you're recording every meeting, every meeting is now discoverable. And so if you have some random lawsuit all of a sudden, you know those like leaked tech emails? Imagine that. But for everything you do at work, all the time, forever, that's what having an AI note taker is in. That's why I just wear my friend. Yeah. Yeah. I mean truly, it is fascinating that like people that we actually got to the outcome where Firefly identifies itself and says like, hey, I'm an AI note taker. I'm here and I'm going to join. As opposed to the alternative, which was just like run cluly on your computer. No one knows. Goldrock says using transcription clankers are a no go. Oftentimes they're used without all party's consent. That's another one. It's like if somebody wants to come in to the call and say, hey, for the next 10 minutes, do you mind if I record this so that I don't have to take notes myself? I'm open to like opting in, but just like the default, record every single call. Like there's no. There's just not something I'm interested in doing. Yeah, obviously depends a lot on the use case, you know. Are you synthesizing takeaways? Is this actually useful? It's probably not a replacement for not actually paying attention during the call. Like you're not just going to zone out for an hour and then review some meeting notes and be like, oh, that was now a productive meeting. I would love to know what percentage of transcripts, like, ever get ready, like the notes. I would expect it to be a very small percentage that actually get read. So it's like one of those things people are like, kind of peace of mind. I mean, I did have one interaction with a group of friends.
Basic stuff. I can chat with it. I don't think people will be driven by that. And also, I just don't think that the whole. It's basically being framed as this, like, big reveal. Like, oh, it's actually teleoperated. When I think that it's just. That's not that much of a. No, I'm a bombshell. Huge teleoperation bull. Yeah. I think that it's even. Even if you're just thinking about a use case for somebody who's like, yeah, every once in a while, I come home late, and I want to put food in my dog's bowl, and I can just tell. Operate my robot and go, oh, teleoperate your own robot. I hadn't thought about it. Yeah, teleoperating your own robot. Like, oh, I'm coming home in a little bit. I want to, like, open the window. I want to open, like, the door to bring in some air or something like that. So I do think it's. I do think it's. Look, you can tell I operate a Porsche. You put the robot in the Porsche, and then you are driving the car. There we go. Remotely. I'm sure there won't be any problem operating the three pedals. So at 75 miles an hour, if. Somebody maybe had a few too many. Drinks, you could put this. So they legally couldn't operate a vehicle. Yeah. Could they tell. Operate on their phone a robot that was driving the vehicle? Absolutely. They're sitting in the passenger seat. I was. I was Teller operating. I've just been sitting here on my phone. I don't know. You got to take this up with him. I love the idea of. Okay, so here's the things. Here's the thing. Let's play out a scenario. So, one, I love that this robot looks unique. I think they have, like, a. I love the color choices that they've used. It's very kind of like, skims adjacent. Almost like they've created a whole kind of cool brand world. Yeah. It definitely feels like more of a. This is a new take on a robot, and they're going for cute. But if this thing is being teleoperated in your kitchen, let's say it's loading, like, dirty dishes from your sink into the. Or from your table into your dishwasher. And then it picks up a big knife, and it just starts moving over, and then it just pauses there. You look over at your robot, and it's just sitting there looking at you like this with a knife in its hand. Are you not going to get a little freaked out. This thing looks cute, but the second it's got, like, a kitchen knife in its hand and it's looking at you, does it really look that cute? Is it cute? I think it's the cutest robot, the cutest humanoid robot I've seen demoed. The question is like, yeah, there's like, this uncanny valley of actually going cute. Because I don't have a problem with just a. I think if you went to the Optimus team and you went to Elon and you said, like, hey, what's your goal for the design of Optimus? I don't know that Elon would say, it's my goal to make it cute. He might be like, no, it's like, the Cybertruck is not designed to be a cute little Volkswagen Beetle. Like, it's meant to look cool and badass and awesome. Right. It's meant to look sick. And I think that there are different optimization vectors to actually go down. The 1x team is clearly going down the cute route, but that doesn't necessarily mean that that's, like, the actual solution to what will get adoption. So I don't know. I think that I would give this like, an 8 out of 10 on the cute scale, but I'm giving it. An 8 out of 10 too. Until it picks up the kitchen knife. And then it goes down. I'm just saying. I'm saying in certain contexts, it's going to look really scary. But is there all humans? So. Yeah, but, like, walk through that. Like, what? Something about. Something about an eyes. Eye without a mouth. Eye without a mouth is maybe an odd choice. Y. Yeah. I mean, it just looks. It looks fundamentally a little bit demonic, not having any other features. But if you add the mouth, then you get more. Uncanny Valley. Right? Isn't that the risk that as you. One thing I don't understand is the pricing strategy. So $499 a month or 20 grand? Yep. Who pays the 20 grand? When you could get. Do you think this thing will be the best robot you could possibly have for 40 months straight? When there's a bunch of companies coming online with robots, wouldn't the default be like, okay, humanoids are going to progress rapidly. I'd rather effectively lease one and know that in 40 months I could get one that's going to be, like, significantly better? Yeah, I would definitely be a leaser. I'd be happy to be a leaser. Just like Satya. Yeah. Let me tell you about Restream One livestream, 30 plus destinations, multi stream, reach your audience, wherever they are. Tyler, you're not afraid of this thing? It's sick. Well, no. Okay, so a couple of reasons I'm not afraid of it. Yeah. One, it's pretty small, right? Yeah. £60, right? Yeah, £60. It's £66. Oh, true. You could totally, like, roundhouse kick this thing out the window. He's a tiny little, you know, guy. You can push him over. Okay. Also, it seems. I mean, nothing. I haven't seen any videos of it, like, really moving quickly at all. Okay. So I'm not afraid that it's going to, like, get the jump on me. Yeah. If it has the knife, I think I can run faster than it. Yeah. And, yeah, I guess I would be a little bit scared if it's being teleoperated. I don't know who's teleoperating. What about in your sleep? Lock the door? Yeah. You could just lock this thing in, like a closet at night or something. Can't really get out. I mean, it's going to be a whole new world when people are like, you know, I'm going to sleep. I'm paying Expert Mode to have my, you know, somebody in my house at the Humanoid. I mean, I'm just not that worried about it because, like, it has been possible to, like, the. The. Like there was some movie about this where, like, the AI oh, it's Fast and Furious in Fast and Furious. Like, doesn't. Isn't there an AI that takes. Oh, no, you won't know. But I think that there's an AI that takes over the cars and, like, drives the cars fast and, like, crashes the cars. There's been other movies where, like, the Teslas have been teleoperated to crash into each other. There was that movie about the. About, like, the doomsday where they all go in the bunker. I forget what movie this is, but there's some. What movie is that? I think Obama produced it. I'm not kidding about that. The. Is it. Don't look up. It's not. Don't look up. It was, like, from the same era. What was it? Leave the World Behind. Is that it? No, it's not Leave the World Behind. Oh, yeah, it is. It's Leave the World Behind. Yeah. And there's that scene where all the Teslas are. Are coming and they're all crashing into each other. Like, that's been possible for a while, but the economic incentives are just such that no one's actually been able to just. There's no one out there that's Just like, oh, I just wanna kill someone randomly and I'm gonna hack all of Tesla's system to take over your car. It feels like something that's definitely possible, but it would require like billions of dollars to actually take over. And at the end of the day, a lot of people just want to make money and so they're like, if I have the ability to go and, and hack into Tesla's network and steal the cars, it's like I can probably just build a car company or something. So some more. Yeah, we're not, you know, NEO factual media here. Yeah. But I do have some facts here from their faq. Will my NEO be fully autonomous? NIO works autonomously by default for any chore request. It doesn't know you can schedule a One X expert to guide it, helping NEO learn while getting the job done. Who are the 1x experts? 1x employees physically present in the USA. Okay, so that's interesting. And then they're also manufacturing NEO in California, which is significant. So my sense is that the unit economics on these are going to be like really, really, really rough initially. Yeah. Because these 1x experts in the USA are by default going to be making a lot more than like $2 an. Hour, this minimum wage. But I guess it, you know, it's going to allow NEO to just get better at a variety of tasks. And so they would be training people to tell or operate or they'd be paying people to tell or operate them anyways. Yeah. And at least they can recoup a little bit of the cost. It's going to be really expensive. This was like the end of my take was like the, the magic here is like it's half actually figure out the technology and half like financial engineering. Because you have to do this extremely delicate dance where you keep the capital coming in and burn and burn and burn. And you're probably burning more every year for a really long time. And then at the end you get the incredible reward. But you have to burn for so long. Get ready to lose capital. And we saw this with Waymo. Waymo was founded in 2009. It's been 16 years and like, there's been some report that like. And people know they're never going to get the cars cheap enough. Exactly. In San Francisco, I think they do have positive unit economics in this like very one in this narrow area. But it's not like a cash cow yet. It's not Google search. Right. Which took like two years before it was throwing off cash basically. Not really, but certainly not 16 years to scale that business. And then you look at VR. How much money has Mark Zuckerberg invested in the Metaverse? How much has, how much money has Reality Labs burned without, without it turning into a cash cow? Like, they're not, they're still not making money off of Reality Labs. And it was the same thing with AI. Like you look at the Satya Nadella deal, like the $1 billion in 2019, like that business was not making money and it had been around for five years already. The company was founded in what, 2015, I think open AI. And so, or the nonprofit was. And so you have, you have these. When you're going after these, like Frontier Technologies, these really broad moonshots, you just wind up burning money for a decade potentially. And can you stay in the game as a venture backed company? It's really, really hard. But at the same time, these types of moonshots are exactly what venture capitalists should be going after. Like this is the goal of venture capital. Quickly, let me tell you about Privy Wallet infrastructure for every bank. Privy makes it easy to build on crypto. Rails Secur clearly spin up white label wallets, sign transactions, integrate on chain infrastructure all the.
Tyler's rocking the hat right now. What about on the regulation front? What are the ways that Poland has, you know, break down Poland's decision making around regulation versus, you know, maybe other members of the eu? So in the eu, you cannot really have much of your own voice on digital matters. So it's actually all been consolidated in Brussels and the European Commission puts up ideas on behalf of everyone else. That's the same for trade. So for instance, when the European Union cut a deal with Trump, it was the EU that was negotiating on behalf of everyone, not Poland, Germany. On Spain. On digital, it's pretty much the same. And there's ongoing debate whether Europe is just overregulating, including AI. And I agree, we are over regulating, or at least there's a perception that Europe is overregulating, which is killing AI. So I'm hoping that the perception will change. And again, newcomers, new guys on the block like Poland, now the 20th largest economy in the world, richer than Japan, with more than $1 trillion of GDP. Poland will be one of the countries that will be pushing for their regulating, for opening up, because it's exactly what has worked well for this country. Did you have to ask Brussels if you could come on our podcast? No, I'm here as an academic author of this book, if anyone is interested. No, but. No. Okay, good. Okay, good. You're like, I had to apply. It was a 10 hour application to go on the podcast. No, it's not quite that. The advantage of the EU is that, for instance, there's now this debate about creating a new regulatory system where you could set up a company which could immediately work all across Europe under the EU laws. So I think they called it sort of the 28 regime. You could sell your products and services everywhere in the EU without worrying about local regulations. And I think this is the way to go. And I think Poland and our region, all countries in the region, will be pushing for these kind of solutions. We don't want Europe to be sclerotic, we want Europe to be successful. And Poles, who are the most pro American society in Europe and probably also in the world, will be one of the big supporters of these changes. Awesome. What's the mood in Poland around energy or what's the. Is there any.
Get to some status where you're like, yeah, actually it's. Would you, would you go into hospitality? Would you create like physical kind of. That's what I was saying. Yeah. If you want, if you want to get 100% of everyone's calories. These European kind of health retreats that are very like evidence driven, they're testing focus. I could imagine a blueprint retreat center that people can visit once a year to. We have about a dozen groups around the world that want to stand this up. And some of the biggest hotel chains around the world, they. Because the thing is they just want credibility. They want to say like, come here. We have this thing structured. When I meet with some of the most powerful people in the world, they're just as clueless as everyone else. It is not like people imagine rich and powerful people will just have it solved. That is not the case. No. And so yeah, we are going to stand this up. We probably will not do physical clinics. It's just too much on the real estate. So we'll probably license it out. Sure. We probably do the digital model. We have IP model almost. We have trust. Like we want to have like we could do a model across food and clinics where we have this evidence based approach. So yeah, I mean we're, we're kind of in it to just blanket the entire industry with a framework on how to do things in a credible way. That's biomarker led evidence based. Yeah. What was the thesis behind the round $60 million tons of faces, not the traditional CPG VCs, private equ.
The costs and benefits of going multi product so soon. Yeah, I mean the thing is that when people want to be healthy, you can't just address one thing. They're still left with 99 things to deal with. I totally get the consumer value makes a ton of sense. So internally we're basically building out the infrastructure to deliver every single channel. So digital food, prescriptions, testing. So we could say like so much stuff. It is so much. You know, like this is what, I've done this myself. I know. You know, like five years we've mastered the system for and you know, I've been fighting to achieve the best biomarkers in the world. Kind of in some sense a like a ridiculous idea, but also like it's a new sport. Like you can imagine it becoming a thing. So yeah, I mean basically we've mastered it, we've built it, now it's productizing. So yeah. So what. Is, how do you think about. So every consumer out there has probably at some point or another gone through the frustration of, of finding a product they love and then watching the company behind it or sometimes an acquirer just like steadily just like try to maintain or increase their margins to the point where it's no longer that. It might have similar looking packaging, but it's no longer the same product. Like I imagine like you want Blueprint to be the thing that you are reliant on for the majority of your calories, the majority of the supplements you take, the majority of the drugs that you are going to leverage. And so I can imagine like you know, holding the company to that standard so that you're not having to go anywhere else or realize like, oh, this product would actually be better for me. But like, do you have any kind of like ethos around that? Because that just feels like every, you know, I try to be cognizant of like when a company goes from founder led to they've exited and the new acquirer is just going to say like, hey, you know, we could actually source this salt from over here and we're gonna save like 80% and nobody's really gonna notice cause it's gonna taste similar. But then the tests start showing up and it's actually like got lead in it now or whatever. Yeah, exactly right. I mean I am Blueprint's number one customer. I appreciate it so much. Cause like we, when we first started doing this project, I was testing everything I put into my body. Air, water, food, everything. And I learned first of all, food is guilty until proven innocent. It is so toxic, no matter where you get it. Yeah. People were freaking out last week when there was that protein powder report came out that a bunch of them had lead in it. And I was like. My immediate reaction was like, obviously a lot of this stuff has lead in it. I mean, like, look at the average chocolate bar has like a ton of lead in it. And that's. It's not even so you can isolate that one toxin, but there's so many other toxins. Totally. So people, they, they grab onto one concept that they understand. It's like, oh, that's bad. There's trace levels of heavy metals in all of our foods. So the fact that it's there is not an alarming. It's just, it's out of context, but it's at a level people understand. But, you know, the goal is I'm going to. Blueprint is my way to try to achieve, you know, this don't die. And so people will be just riding along. We build on population level data. So this is not about Brian Johnson's body, this is about everybody's body. So all ages, both genders. But no, I think we're being meticulous about what we do. And so it will be. The quality will be the best in the world. And so I care about it. I'm consuming all about myself. Yeah. What's the plans on the kind of telemedicine front for kind of interventions or therapies that require doctors kind of involvement? Is there anything on that front? We will build an infrastructure to. Basically when you want a prescription, if you want to go on a GLP1, we can help you get started, whether you want a large dose or a microdose. This is funny. You're just like, yeah, and also I'll do the lab testing and also like build the, you know, the. I'll be mining the metal that gets turned into the needle that injects you with the gel. You want, you want to hold up the entire global economy. I love it. It's good ambition. I strongly support this. Yeah, I was interested in like, where are the edges of like, what you. Yeah, actually I'm not going to go into that market. But it feels like you'll just continue to work on it until you get to some status where you're like, yeah, actually it's. Would you go into hospitality? Would you create like physical kind of.
Year ago. What's your, what's your view on. I think everybody's hoping maybe, maybe GLP1s are this. And people haven't sort of fully realized it yet, but everybody is kind of, I feel like for a while just hoping that like, oh, by the time that I'm, I'm really aging, like I'm really feeling it, there will just be a pill that I can take and you know, I'll just be able to halt or maybe even reverse. Are you like how open to, to you. How open are you to the idea that there could be something that is an order of magnitude more effective than GLP1s in terms of anti aging? Where do you put the probability there? I mean, that study that came out from China in June, they showed that they took this form of a FoxO3 protein. They used CRISPR, they put it in a mesenchymal stem cell and delivered it via intravenous treatment. It had a biological equivalent for human anti aging. So this was in monkeys. It had a three to five year age reversal in over 50% of the tissues, which is unseen. And then for a human equivalent, that'd be like nine to 15 years roughly. So these demonstrations are being done. I think we'll probably. I was going to actually figure this out. You know the hype cycle where you. Yeah, Gartner, hype cycle. Exactly. Yeah. Trough of disillusionment, plateau of productivity. I was going to model this out this week, try to figure out like, because I think we're probably going to hit peak in something like GOP1s or something. 2032. You like ish. Like okay. Like, okay, we got some time. A few things are here and people will be like, it's here. And people will think that they're going to live forever and then there will be a crash and be like, oh, actually there's still more problems to solve. Exactly. 2035, 2037. People are like, oh man. Like it's not solving this or that or we have these complications in like maybe early 2000-40s. People are like, actually, yeah, we got this. Something like that. I saw some post you get, you. Get crazy inbound from for mad scientists all.
Like, need a killer app. That sounds like something you should build. What do you think? Yeah, I mean, the. If you think about it, GLP1s are kind of that. I mean, a little bit, right? It's like, it's like modulating your hunger, your satiety, and it's like. So how do you think we'll view GLP1s and the explosion of their use? In 50 years. It'S probably the most successful anti aging drug ever built. It's incredible. It's like the benefits keep on accumulating. Yes, there's drawbacks. They're getting better all the time. But do. You feel the same way about statins? They're complicated. I mean, statins do have benefits, but they're complicated. Do you feel.
Science with maybe stagnation in regulatory. What's your framework for that? Yeah, I mean, peptides are very powerful. They're basically drugs. So you get access to drug like effect sizes. The problem is peptides are oftentimes not manufactured to spec. And so you have risks of putting stuff in your body that you shouldn't be putting your body. They could have lead in them just like your chocolate bar. And a bunch of other stuff. Same with stem cells. So there's a real quality problem. Yeah, yeah. The other problem is peptides. A lot of peptides are not fully well characterized. So typically drugs, you say like, you can do this thing, but also here's the long list of side effects. And that's nice because it's like, okay, at least I know what the trade off space is with these peptides. You don't have the characterization. Okay. And so it's a bigger risk that people experiment. You see a lot of this in bodybuilding. Now you have biohackers doing it, so it's fine. It's just, you have to understand it's the wild, wild west that may be your game, it may not. But like, it's definitely. You want to be cautious. Sure. It's not like it's a safe path. But then there's other things. Like you start with the highest level of evidence. Sauna is great, but I've talked about the.
Way. That's biomarker LED evidence based. Yeah. What was the thesis behind the round $60 million, tons of faces, not the traditional CPG VCs, private equity folks. Like, what was the thesis? Yeah, I mean, so I. I've been funding the company myself up until this point. Yeah. And, you know, I guess I just wanted my friends to come along with me. So these are people I talk to in private. They enjoy it. They're into it. Yeah. And I think a lot of people, they have not known how to think about me. Like, am I legit? Am I not Is weird. And then they see that list of investors are like, oh, yeah. And so like yesterday, I think it was the first day, it was like, oh, it's safe to say this is cool. That flipped like a long time ago. Really? Yeah. I feel like the first, like, business. What was the first piece that you did that was like, I spent $2 million on my health and that went super viral. Yeah. Two or three years.
Of minutes that you spent online. Each CD would give you a couple thousand minutes for free. Something along those lines, anyone? Anyway, we have our first in person guest of the show, we have Brian Johnson. Welcome to the stream. Go over there while he hops on. Let me tell you about A.I. google. Google A.I. studio. The fastest way from prompt to production with Gemini, Chat with models, vibe code and monitor usage. Thank you. Classic LA story to see you again. People in L. A arrive on time 15 minutes after you normally arrive. Oh yeah, at least I do normally. Yeah, that's the nature. Hopefully you didn't have too much traffic. It's great to have you here. Big week for you. It's been a great week for us. Yeah, congratulations. 60 million. But break down exactly what happened. What was the impetus for the deal? Take us through the recent history of blooper. I mean I started this. This is the idea that we are the first generation who won't die. It's kind of a crazy idea. We started this a couple years ago and I think a lot of people thought this was kind of an insane thought process. And so we've been hammering away and I think it's gone from weird to interesting to yesterday was kind of like now it's accepted and maybe even cool. Yeah, yeah. And so I think we've, it's a, it's a thing now. It's a part of the zeitgeist and I think it formalizes that we're really going to take a shot at this. Yeah. So I mean there's like the philosophical underpinning where you're, I imagine, you know, in, in the vein of Kurzweil, like looking at long term trends, artificial intelligence, compounding, just the value of compounding little gains all over the, the health system potentially could, at least in your belief, get us to infinite life and not die, don't die. So you get to that. But then you, you know, at some point need to instantiate that in company, in a business, in a suite of products. And so that's what blueprint is today. Is that the idea of the fundraise? Is that what people are investing in? Yeah, the idea is when somebody says yes, I want to be healthy, it's pretty hard. You have to go out and you have to navigate a thousand things, you know, like is this good for me or is it bad for me? People who have conflicting opinions. And so our target customer is somebody who says I want to be healthy. And, and we just say we've got you, we will give you the protein amounts we'll give you tested and certified foods, we'll give you the exact dose, we'll help you with your prescriptions, we'll give you protocols, your autonomous self. It's not go navigate the world by yourself, it's we've got you. And we'll do an evidence based biomarker approach. One of the. I feel like anybody that really gets into health goes through a period where they realize I, at least at one point, I was like 19 at the time, realized that I felt, felt like I was spending like 50% of all my cognitive power on just like trying to be as healthy as possible. And at a certain point I realized like, this is such an inefficient use of time. Fortunately, you build up some habits and kind of like understanding of what's good and what's bad and what you want to leverage more and kind of avoid and all that stuff. But I think like make, you know, removing that step from the process of being able to just kind of like default into a system walk. Can you get into a little bit more of like, I remember reading a post at this point from you, maybe it was like a couple months ago, kind of like talking through the decision making around, you know, where you wanted to take blueprint, why kind of raise capital, all that kind of thing. Yeah, I mean, it was this. I mean, I guess I. My sole objective is try to be sober in this moment. And I really enjoy the perspective of thinking a few hundred years into the future. You look back at this moment and we are giving birth to some kind of superintelligence. We don't know what it is, we don't know what kind of scale, but it's big, it's important. I have neither an opinion that it's positive or negative. It's just significant. And I was really trying to think through, does it even matter if I build anything in the world right now, or should I work on building the philosophy and the moral framework on what does it mean to be intelligent on planet Earth in this part of the galaxy? And I was kind of in the middle as an entrepreneur, do you build or which way do you build? And so I was just reflecting that, am I misallocating my time? And I thought, really, blueprint is the practical implementation of this philosophy. When you say yes to don't die, you're saying, I value existence, I respect existence. And so it's less about living forever, it's more about a philosophy of yes, this moment is big. And so what a lot of people don't realize is this endeavor is entirely about AI alignment. I mean that's the sole thing happening on the planet right now. And so when you take care of yourself, you take care of your body. When you take care of the body, you take care of intelligence. It's this holistic system of we acknowledge existence. So that was it. It was like I was trying to figure out as a human, what do I do on planet Earth right now and how do I spend my time. I'm an entrepreneur. What my intuitions are to become an entrepreneur. But I wondered, is that really the right way to do it? Yeah, yeah. What is, what does blueprint look like in a decade? It feels like you're, it's such a unique consumer packaged goods business because you can't even call it that. It's like, I mean I understand that there's like the philosophy and I love that as the brand, but even just in terms of like the business of like what people pay for, there's a lot and that's just that, just such a contrarian approach to the this category because so many people are like I have an idea, I'm going to make coffee better, I'm going to make a greens powder better. Or I have an opinion about the burger or the meat or the food or one particular thing. And then they grow and grow and grow. And then five years in they're like, let's do a line extension. Let's do something. Yeah. The CPG trend of the last 10 years was go walk into the gas station, find a product that's popular and make a version of it that's like 50% healthier. And then you probably have like a nine figure revenue business or make nothing. Like Thrive Market erewhon. There's a bunch of companies that have been like, we're just be the seller of everything. How did you land on like I want to kind of make everything. That feels like an immense challenge. I want to walk through all that. I mean that's what you know, Karpathy was talking about the autonomous systems with door cash. Yeah, like that then. And he and I think very similarly in this way is that if you model out what AI systems will do, they'll probably take on more autonomous responsibility. In our lives we see beginnings where you plug an address into a car and it helps you navigate to the place. You don't think about it much. We're going to build our autonomous self. Our health will be run on our behalf. So right now we have to chase down all our food to chase down protocols. We have to Chase down evidence. But it's not going to be that in the future. It will be that it will just be run for us and as we get measurement that's more high fidelity. So blueprint is basically we're saying we are going to build your autonomous system of health and we're going to ride the breakthroughs of science so that as we make better progress in lowering the speed of aging and reversing aging damage, you could just say I'm in and I'm going to ride with you. We're going to try to be on the very, very forefront to help people have the best possible health. So we're just building out autonomous health systems. Yeah, that feels like super valuable just from the consumer experience of like I'm delegating all of that hassle. I have a no. Basically if I buy one from one brand, it's all aligned with one philosophy, which is great. What does that mean on the logistics side? What does that mean on the capex side? What does that mean on the operational cost side? Do you have like 25 different product managers for each niche? Like what's the shape of the company? This feels like a big challenge, a very big challenge. We're standing up like 10 different businesses at the same time. Exactly. Like there's plenty of people that could have done what you did where they like become famous or they become content creators in one way or another. And then they're like, now I have one product and you're like, now I have. How many products do you actually have? Over 20 to over 20. Yeah. And it's clear that like you probably a lot of that comes from the fact that you've been a successful entrepreneur before. You're like, yeah, I can probably do more than just one. But, but what actually does the, what does the, does the business look like? Does the system look like. Are there cross selling benefits in retail on day one or is this just an E commerce play on day one? Like how do you think about the costs and benefits of going multi product so soon? Yeah, I mean the thing is that when people want to be healthy, you can't just address one thing. They're still left with 99 things to deal with. I totally get the consumer value makes a ton of sense. So internally we're basically building out the infrastructure to deliver every single channel. So digital food, prescriptions, testing. So we could say like so much stuff. It is so much stuff. You know, like this is what, I've done this myself, you know, like five years. Yeah, we've mastered the system for me. And you know, I've been fighting to achieve the best biomarkers in the world. Kind of in some sense a like a ridiculous idea, but also like it's a new sport. Like you can imagine it becoming a thing. So yeah, I mean, basically we've mastered it, we've built it now productizing. So yeah. So what were the edges of the. What is. How do you think about. So every, every consumer out there has probably at some point or another gone through the frustration of, of finding a product they love and then watching the company behind it or sometimes an acquirer just like steadily just like try to maintain or increase their margins to the point where it's no longer that. It might have similar looking packaging, but it's no longer the same product. Like I imagine like you want Blueprint to be the thing that you are reliant on for the majority of your calories, the majority of the supplements you take, the majority of the drugs that you are going to leverage. And so I can imagine like, you know, holding the company to that standard so that you're not having to go anywhere else or realize like, oh, this product would actually be better for me. But like, do you have any kind of like ethos around that? Because that just feels like every, you know, I try to be cognizant of like when a company goes from founder led to they've exited and the new acquirer is just going to say like, hey, you know, we could actually source this salt from over here and we're going to save like 80% and nobody's really going to notice because it tastes similar. But then the tests are showing up and it's actually like got lead in it now or whatever. Yeah, exactly. Right. I mean, I am Blueprint's number one customer. I appreciate it so much, you know, because like we, when we first started doing this project, I was testing everything I put into my body. Air, water, food, everything. And I learned first of all, food is guilty until proven innocent. It is so toxic no matter where you get it. Yeah, people were freaking out last week when there was that protein powder report came out that a bunch of them had lead in it. And I was like, my immediate reaction was like, obviously a lot of this stuff has lead in it. I mean, like, look at the average chocolate bar has like a ton of lead in it. And that's. It's not even so you can isolate that one toxin, but there's so many other toxins. Totally. So people, they, they grab onto one concept that they understand it's like, oh, that's bad. There's trace levels of heavy metals in all of our foods. So the fact that it's there is not an alarming. It's out of context, but it's at a level people understand. But the goal is I'm going to blueprint is my way to try to achieve this. Don't die. And so people will be just riding along. We build on population level data. So this is not about Brian Johnson's body. This is about everybody's body. So all ages, both genders. But no, I think we're being meticulous about what we do. And so it will be. The quality will be the best in the world. And so I care about it. I'm consuming all about myself. Yeah. What's the plans on the kind of telemedicine front for kind of interventions or therapies that require doctors kind of involvement? Is there anything on that front? We will build an infrastructure to. Basically when you want a prescription, if you want to go on a GLP1, we can help you get started whether you want a large dose or a microdose. This is funny. You're just like, yeah, and also I'll do the lab testing and also like build the, you know, the. I'll be mining the metal that gets turned into the needle that injects you with the gel. It's like you want to hold up the entire global economy. I love it. It's good ambition. I strongly support this. Yeah, I was interested in like, where are the edges of like, what you really. Yeah, actually, I'm not going to go into that market, but it feels like you'll just continue to work on it until you get to some status where you're like, yeah, actually it's. Would you, would you go into hospitality? Would you create like physical kind of. Yeah, if you want. If you want to get 100% of everyone's calories. These European kind of health retreats that are very like evidence driven. They're testing focus. I could imagine a blueprint retreat center that, that people can visit once a year to. Yeah, we have about a dozen groups around the world that want to stand this up. And some of the biggest hotel chains around the world, they. Because the thing is, they just want credibility. They want to say, like, come here. We have this thing structured. When I meet with some of the most powerful people in the world, they're just as clueless as everyone else. It is not like people imagine rich and powerful people will just have it solved. That is not the case. No. And so, yeah, we are going to stand this up. We probably will not do physical clinics. It's just too much on the real estate. So we'll probably license it out. Sure. We probably do the digital model. We have IP model almost. We have trust. Like we want to have, like we could do a model across food and clinics where we have this evidence based approach. So yeah, I mean we're, we're kind of in it to just blanket the entire industry with a framework on how to do things in a credible way. That's biomarker led, evidence based. Yeah. What was the thesis behind the round $60 million? Tons of faces, not the traditional CPG VCs, private equity folks. Like, what was the thesis? Yeah, I mean, so I've been funding the company myself up until this point and I guess I just wanted my friends to come along with me. So these are people I talk to in private. They enjoy it, they're into it. And I think a lot of people, they have not known how to think about me. Like, am I legit? Am I not? Is this a thing? Is it weird? And then they see that list of investors are like, oh, shit. And so like yesterday, I think it was the first day, it was like, oh, it's safe to say this is cool. Cool. People have been like flipped like a long time ago. Really? Yeah. I feel like the first like business. What was the first piece that you did that was like, I spent $2 million on my health and that went super viral. Yeah, two or three years ago. That was like two or three years ago. I feel like that was the moment. Where people were, I always looked at it. My personal view was pretty quickly people dug into your backstory and were like, oh yeah, you sold them. Yeah. My personal view is America has over the last few years had so little trust and health institutions, like, if you just went and followed the American Heart Association's guidance, I'd probably die at like 6 to 9. So. So to me, I was always like, you know, knowing how much I, I. You can read about health and you can listen to podcasts and you can listen to what some influencer said in a short form, video. But to deeply understand your health, you have to do self experimentation because everybody is different. And so I always looked at it. You always tried to be controversial enough to generate attention, attract some people that were going to become super fans and lose some people. And you were kind of okay with that. But my sense was always like, thank you. That somebody is going to invest more money than basically anyone else. And Just self experimentation and then open source, all of that. And now people can buy your olive oil if they want, or they can decide, no, I'm actually going to go on my own journey and try to find some product that can fit this requirement. But it felt like such a public benefit that I always wish there was like a thousand Brian Johnsons that were just all running the same experimentation, open sourcing process versus the biggest thing we talked about this the other day is health influencers quickly get into put themselves in a niche and they're like, I'm the fasting guy, I'm the HRV guy. And then every single thing becomes about that. Yeah. And it's cool. Cause you can like tap into a world and like kind of accelerate and understand a lot about a category. But then in reality, it's not like fasting is the only thing that matters. It's just like one tool. So I have another take on that that maybe I'd like your reaction to. There's also this trend in health influence where if I want to blow everyone's brain, I'm going to come in and blow everyone's mind. I'll be like, guess what? I boil it all down. It's sleep, diet and exercise. That's like 99% of what you need to do. And everyone's like, man, this John guy, he's not talking about the crazy supplements, he's just telling it like it is. Sleep, diet, exercise, I did it. I feel great. This is amazing. And then after I've made one hour of content every week for five years on sleep, diet, exercise, I'm like, you know what, let's actually talk about the 17th piece of magnesium you should take or the thing that's, yeah, it is beneficial, but it's 0.001%. And it's still interesting. But it's not going to have the power law effect of actually start working out or like actually get sleep. And so do you wrestle with that? Do you feel like you have to go back to the basics sometimes? Or do you think that there's actually maybe that's not even a reasonable critique? Yeah, I think that the thing that most people struggle with is doing things they don't want to do. Like they don't want to overeat, they don't want to eat a pint of ice cream, like they don't want to drink, you know. So, yeah, those things are really the highest leverage interventions. It's behavioral. And so, yes, you can say sleep, that exercise. But you get deep and you then Uncover that American, like our American society is one of addiction. Sure. Like the American powers of capitalism have appointed at getting people to be addicted. Food, sugar, nicotine, porn, junk food, all of that. And so this is, if you look at. So like just from a broad perspective, you begin on western thought with Plato, Aristotle, Christianity, medieval times, Renaissance, Enlightenment and modern scientific era. Like you look at these big frames, we're due for a major shift and right now we're at the tail end. This is like kind of a dalio kind of thought process of like these big macro trends. We're at the end and right now capitalism was for solving scarcity. We're now compulsive. We're now compulsive. And the idea was democracy was freedom of choice. We now have no longer choice because we're addicted to. So we're really playing on this very big macro frame of we're at different times of species. And so yes, sleep, diet, exercise. But in this larger frame it's about what does it mean to actually be intelligent, make decisions and you can't when you're addicted to everything. Yeah. What do you think about some of the longer tail interventions? Like the third peptide that's not approved yet, but people are already taking it here. It feels like, is this sort of like pseudo regulated, unregulated biohacking becoming more prevalent? Is that the correct world in a world where the FDA is broken or does the FDA need to change? Or how should we map the accelerating advances in science with maybe stagnation in regulatory. What's your framework for that? Yeah, I mean, peptides are very powerful. They're basically drugs. So you get access to drug like effect sizes. The problem is peptides are oftentimes not manufactured to spec. And so you have risks like putting stuff in your body that you shouldn't be putting your body. They could have lead in them just like your chocolate bar and a bunch of other stuff. Same with stem cells. So like there's a real quality problem. Yeah, yeah, yeah. The other problem is peptides. A lot of peptides are not fully well characterized. So typically drugs you say like you can do this thing, but also here's a long list of side effects. And that's nice because it's like, okay, at least I know what the trade off space is with these peptides. You don't have the characterization. Okay. And so it's a bigger risk that people experiment. You see a lot of this in bodybuilding. Now you have biohackers doing it. So it's fine, it's Just, you have to understand, it's the wild, wild west. That may be your game, it may not. But like, definitely you want to be cautious. Sure. It's not like it's a safe path, but then there's other things. Like you start with the highest level of evidence. You know, sauna is great. Yeah. But, you know, like, if you. I've talked about this a lot. If you don't ice the boys in the sauna. Sure. You crush. Can you make a ice pack? So I used to. I used to. I think we maybe talked about this last time. I used to. There used to be this ice pack on Amazon that was for this use case and they stopped selling it. And I don't. I, Like, I lost my. So we should. Yeah, they don't want you icing your voice. I don't think they want that. Yeah. And then a lot of men will say, like, I'm not trying to have, you know, babies, so it doesn't matter, but negative feedback. Hormone. Hormone health. Exactly. Interesting. So, yeah, there's so, yes, sleep, that exercise is great. But then you dive into the details. This is what I'm saying. Like you, you start down this path and you inevitably will spend 50% of your time chasing down everything. Some sort of weird root cause. All these things, whatever it is, it's never easy. So you have infinite chase. And that's what I'm saying is that's the problem. Trying to solve is nobody has 50% of our time to do this. How are you thinking about wearables? Because there's a world in the future where you have a camera that's effectively a sensor that's able to experience life in your view. And that as a health copilot, would be pretty wild because you'd be like, hey, hey, you've already eaten. Well beyond. You assume that cameras get better at calorie tracking. It's like, hey, you're well over your daily caloric needs. You're now going into a surplus. Maybe ease off and maybe that's enough. Meta ray ban displays, like, need a killer app. That sounds like something you should build. What do you think? Yeah, I mean, if you think about it, GLP1s are kind of that, I mean, a little bit, right? It's like, it's like modulating your hunger, your satiety. And it's like, so how do you. How do you think we'll view GLP1s and the explosion of their use in 50 years? It's probably the most successful anti aging drug ever built. It's Incredible. It's like the benefits keep on accumulating. Yes, there's drawbacks. They're getting better all the time. But do you feel the same way about statins? They're complicated. I mean, statins do have benefits, but they're complicated. Do you feel like there's any value to reading into the conspiracy? Like, weird vibes around the fact that like, Ozempic came from a demon like this Gila monster, Isn't that what. Yeah, the Gila monster. Is it the Gila monster or Komodo dragon venom or something like that? Like, it just feels like wrong. Right. If you're just like, you know, just humanity 101, you'd be like, yeah, don't drink. Don't become the reptile. Don't drink the reptile venom. I mean, you're Brian, maybe trying to become the reptile. Are you into it? The sonoran Toad gave us 5 Meo DMT. And I would say that that's bad too. That throwing off all sorts of red flags for me. It just got FDA approval. It did, it did. For what? Break the status for treat depression. Resistant depression. Yeah, yeah, yeah. Treatment resistant. Got it. Yeah. So, yeah, I mean, I guess if you're sad, you need the toad to cheer you up, I suppose. Thank you. I'm happy. If it's helping people, I'm happy. It is just funny. When we were looking at the story of Ozempic like a year ago, what's your view on. I think everybody's hoping maybe GLP ones are this and people haven't sort of fully realized it yet, but everybody is kind of, I feel like for a while just hoping that, like, oh, by the time that I'm, I'm. I'm really aging, like I'm really feeling it, there will just be a pill that I can take and, you know, I'll just be able to halt or maybe even reverse. Are you like, how open to. To you. How open are you to the idea that like, there could be something that is like an order of magnitude more effective than GLP1s in terms of anti aging? Like, are you, you know, where. Where do you put the probability there? I mean, that study that came out from China in June, they showed that they took this form of a FoxO3 protein. They used CRISPR, where they put it in a mesenchymal stem cell and delivered it via intravenous treatment. It had a biological equivalent for human anti. So this was in monkeys. It had a three to five year age reversal in over 50% of the tissues which is unseen. And then for a human equivalent that'd be like nine to 15 years roughly. So these demonstrations are being done. I think we'll probably. I was going to actually figure this out. You know the hype cycle where you. Yeah, Girtner, hype cycle. Exactly. Yeah. Trough of disillusionment. So plateau of projects. I was going to model this out this week, try to figure out because I think we're probably going to hit peak in something like GLP ones or something. 2032 ish. Okay, we got some time. We're still going on. A few things will hit and people will be like, it's here. And people will think that they're going to live forever and then there will be a crash and be like, oh actually there's still more problems to solve. Exactly. Then 2035, 2037. People were like, oh man. Like it's not solving this or that or we have these complications in like maybe early 2000-40s. People are like, actually yeah, we got this. Something like that. I saw some post you get crazy inbound from for mad scientists all over the world. They're like, hey, I made this thing. I was talking with ChatGPT for 50 hours over the last week and I figured out like, let me, let me come inject you. When I was, when I was building kernel with this brain interface. Yeah. I would get all these emails that people are like, I've been implanted by the government. Oh. So that would come in. But now, yes. Like I do. I get I don't know, maybe like seven to ten a day. Whoa. People offering you experimental. You know, like I've, I've discovered the quantum realm and how the. How sick. Yes. I mean it's wild. People are excited about this topic. Maybe some toads involved in that one. That's funny. Yeah. I remember seeing this post a while back. I don't know if you remember it better than I do, but it was basically looking at like the distribution of lifespans is not. There's not just a single power law where everyone falls off at like 90 like you would expect if it was just a normal power law that we would get a couple hundred fifty and like one two hundred year old person. But in fact there are like this double exponential effect. Yeah. And so maybe that's kind of what happens where you. Maybe we solve one of them. But then we still are at this like, you know, exponential fall off in longevity. But even unlocking like one person at 200 would be amazing. Yeah. Yeah. There was this Interesting paper that came out of Levin. He said his theory after running this model was that basically, after we reproduce, our cells lose purpose. Like, our cells don't have a unifying objective. Yeah. So they just like aging. Just, like, we just don't know what to do. Interesting. So if his model is correct, like, biology needs. Don't die. Like, they actually need an objective at a macro scale, like at our level of cognition, but also at a cellular level. But these are the kinds of experiments people are doing of, like, what is the underlying incentive structure of biology? Why do we age? Why do we not age in certain parts of our life? Why do we have protective mechanisms? Why do some species regenerate? So I think it's this really exciting frontier where our ideas now of aging are beginning to crack open a little bit and expanding our horizons. Like, how do we think about time? I mean, we talked about this last time. You were on about Warren Buffett, Charlie Munger, not particularly famous for their biohacking, but incredibly resilient, like a life well lived. So many stories about them, like, you know, staying up drinking Coca Cola and wine long into the night. And I want to believe that there's some level of just. If you have a purpose, if you have drive, your body just pulls it together a little bit more. I know people want this to be, like, the answer. I think it's really such a bad idea because people, in their mind, they make that shortcut in their mind, like, you know what? I'm just going to work harder. I got to work harder. Yeah, yeah, yeah. Did we. Did we cure balding? There was that study, was it last week. They're all such. They're weak effects. Yeah. We really have not made. I guess it's so long, turkey. It's a little bit embarrassing as a human race that we haven't been able to make really good strides on hair loss. That one seems very simple. I don't know, it just seems, like very mechanical. You know, it doesn't seem as complicated as, like, you know, your brain degenerating. We don't even know how the brain works. It's like it's hair. It just grows like it should be. We're working on it. We just put out our best attempt. We're going to see if it works. Like, we're going to try to be. Everything is out there on market. We'll see. How important is these, like, cosmetic intervention to the blueprint plan? Because you could imagine a world where people will say, yeah, make me live forever, but I don't Care about wrinkles and hair because unless it's going to help me actually live longer. Yeah, why bother? I mean the thing is, don't die is really be hot. Like what, what Every, every, every, every supplement company, every, every company in health you're ultimately selling. At the end of the day, I. Think this is brilliant from a business perspective. But does it make sense in terms of the science? Like does it take something out? Yeah, no, like being hot is good science. You know, like if you look youthful and vibrant, your skin is nice and like you, you're, you have a lot of energy. So I think be hot is legit the path for this. Okay. Yeah. Be hot, don't die. How do you think about longevity in the business? You know, if you look at the D2C bubble, there was a lot of companies that raised similar amount of money and you know, are no longer with us. I imagine you care about a lot about just making sure that don't die and blueprint survive decades. And I'm sure that's informing the way you're building. I mean this is like you, you know the Internet, it comes about Google sets up shop and rides that tailwind. Amazon sets up shop on commerce. Right. Basically somebody's going to set up shop in longevity and ride a multi trillion dollar ride. Sure. So that's what we're trying to do is we're trying to just be home base, win the early innings of longevity and then ride for the multi trillion dollar market. Yeah. Do you think there's a lot of like I imagine M and A will be pretty important to your strategy? Really a lot of companies, I mean I just view there's a lot of companies that are important that are like single product or for specific use cases that don't really necessarily need or shouldn't be because like if you're a blueprint customer, maybe you need it once every three years but that means it could be harder to actually build a business around, but it would slot in. You nailed it. So basically if you look at the landscape in health right now, nothing is proprietary. You basically you've got wearables from all these different providers, you have food from providers, you have biomarkers. Like nothing's proprietary. And so the winner's going to have to out compete everybody and bringing an experience to the customer that is sensible and practical and make, you know. So I think that's, that's where the competition is going to be because this is like the days when I was building a braintree. Venmo is, it was commoditized like you're all in the Visa, MasterCard, IMAX, Discover Stack and you have to build something unique and then Braintree and Stripe just collapse the market. Yeah. How do you think about now? I want to hear the story of the Venmo acquisition. How did that happen? They, so they built up a vent so people in payments. It was very clear PayPal was the only company making money. Okay. Because they had both sides of the market. Sure, they got lucky because they got into ebay, they built the consumer side, but then they had the merchant side too because otherwise if you just offer it to merchants, your margins are pretty low. You're making whatever 20, 50 basis points like that. And so everybody was going after PayPal trying to build a two sided marketplace and that took a lot of capital. It's very hard to build from scratch. And so I said, okay, I'm going to build the merchant side of the business first and then I'm going to acquire the consumer side. I said this when I started the company. So we got customers like Airbnb, Uber, GitHub, we got all the Gen Z people and then Venmo had done a fantastic job building out consumer side. And we could then marry those two demographics and we'd say perfect. And so yeah, so they had built a great business but they hadn't solved making money. Okay. When they plugged into our world, we bought them for 26.2 million. Yeah, yeah. How much of that was like not making money because of fraud? I hear that like a lot of fintech companies, like they actually have something where the unit economics should work. But it's always crazy. In the early days you hear the story about PayPal where PayPal was losing tons of money, but it was only because of fraud. The actual business, when it wasn't fraudulent, made sense. But then once you get to scale, you can do the anti fraud properly. Is that something that you were problem solving? It's very hard because you're doing peer to peer and typically you have like illicit purposes primarily as your driver. And so it's a very hard problem. So as a standalone it's hard for them to make sense because you, if you have, if you stack on a fee when you're paying your buddy, it's hard friction in the adoption. So you have to kind of speed run adoption and then make money later. Yep. But there was no good make money later problems. Do you think? Do you. I was running, I think it was a shower. Thought I was like, okay, there's so much capital sloshing around the private markets. It's been interesting that we haven't seen more people, like, try to take on Stripe. I don't know if it's. I don't know. I'd be curious. From your point of view, at what point will people even try to climb that mountain? Very unlikely. They've done such a great job executing. I sold Braintree in 2013, so they've been building 12 years since. They've done such a good job making that airtight. They're just great. This is the thing is like, yeah. You can't come in and make a 10x better product. Amazon locked Commerce. So you, of course, can build your e commerce business on Shopify, but at a scale. I mean, Amazon has just kind of owned that entire thing. It's very hard to replicate that. So that's our goal too, is we're basically trying to do that for longevity is once you collapse the entire space, it's just very hard to get in. Okay, we got a lighting round. Favorite book or just a book recommendation? Something you read recently that you like? I just finished the History of the Western Mind going through all of Western thought. Oh, cool. Favorite music? What's in your. You know, I have such a soft spot for Eminem. When I was depressed, he was the only artist that I could feel okay. Love it. When will humanity develop AGI? That's your heart. You don't want to sound like a D cell. You don't want to be. Yeah, yeah. Just call it right now. Yeah, Well, I want to be able to clip this a day and be like, exactly. I want to say. I want to say that. I want to say that we'll be next to you and we won't clip this, but I know our clipping infrastruct, and we absolutely will. It's such a sucker question. Well, maybe. Let's flip it around. OpenAI years after this deal where. Where the definition of AGI will be convened by a group of experts. What is your definition of AGI? I approach this question as a more through psychology of when will humans feel useless? Feel useless? Yes. Like, our entire identity is based upon, like, we do things, we contribute, we build. And now AI is a tool. Like, we feel more productive with it. Yes. At what point Will do everything so well? You feel this deep hole in your stomach of, like, what do I do? So what if? Yeah. The weird thing is, like, computers are incredible at chess, yet people play chess for fun and at the professional level because humans, I guess, they're anti clanker and they like watching humans play chess. And if we can solve that for everyone so that everyone has some sort of, like, in this AGI world where there's no more real jobs, there's no more actual, okay, you need to produce something for food or, you know, livability. Everything is just for fun or for games and for status. And it's all about. Wasn't Andrej Karpathy saying, you go to the gym and you'll learn in the future? And it's. And I wonder, like, if your definition is once that breaks down, that is. Feels really far. Exactly. I like that. I like that people look forward to retirement. Retirement is a goal. It's an ideal. It's like when you get an rv, we're going to cruise the country, then they retire. They're like, this sucks. There's not the tension. Never retire. So if we imagine we're going to learn and we're going to do yoga all day and paint, but if there's not the tension of the stress of real life, do we really want to be on vacation all the time? Do we want to be at leisure? So that's my. What I think about is when that happens, that's a pretty unnerving situation because humans don't do well with that uncertainty. And then our systems have to respond. So that's what I really think about all day, every day. Everyone in the end is just going to be competing on biomarkers. It's going to be the final step. It might be. This is the final game. It might be the final. That aligns with Carpathy's take. Last lightning round question. And then I want you to ring the gong. Favorite vacation spot. Where would you go? Redwood Forest. Redwood Forest. I love redwood. Staying in California. Yeah, I would love. I love redwoods. Let's go. Right like there. This is John. There's John. I love California. You don't need to go to Europe. I love America. I don't. You don't need to get all the radiation on the plane. Yeah, just stay here. They're like such beautiful, majestic creatures, and. They live a long time. They live a long time. It's very on brand for you. I love it. Congratulations on the round. $60 million. Fantastic progress. I'd love for you to ring that gong. And I'd love for you to ring it at a. At a decibel level that you feel is appropriate for hearing. We don't want to. You know, actually, let me. Yeah, let me pull up. Can you teach us? Yeah, let me pull up my decibel Meter. Do we have my phone? Let's make sure we get this. Yes. Let's bring over. We don't want to be over 80 decibels. Okay. Yes. Because we do have IEM, so it is a little bit of hearing protection. But I would love to know you can feel free to take as many swings as you. As you need. I'd love to know what an 80 decibel ring sounds like. So, yeah, I recently I measured my ears. My left ear is 64, so I have moderate. Mild to moderate hearing loss. Oh, really? Which substantially increases your risk of dementia. Oh, whoa. So, yeah, because you're going crazy because you don't perceive reality problems, your brain's. Missing all these things. Wow, that's crazy. Makes so much sense. Built for hearing loss, like concerts, social gatherings, restaurants. So, yeah, I would suggest everyone get a hearing test. Yeah, I just get hearing aids. Okay. So. All right. Okay, cool. Here we go. Yeah. Hit that gong at a longevity approved level. Let's hear it. Okay. What are we at? How are we doing? 90. 90. Okay, so about that level. If we go any higher, we're going. To need just a tad. Yeah. Yeah, just a tad. There we go. That is the Brian Johnson and probe approved gong. Hit. You heard it here. I bet everyone in the chat is like, oh, finally. That's funny. We smacked that thing so loud. Fortunately, you know, we. Dude, do you have tinnitus? No, I don't. Okay. Fortunately. But I do. Oh, you do? I've had it since I was my Coachella era. This is the thing. Yeah. Yeah. Wow. Yeah. Now I don't go to concerts at all. I don't pay to stand in crowds and lines. But I do. I specifically recall or I believe I know the exact weekend that it started. Man. Is it a pretty significant thing in your life? No, I zone it out. But if I take a. Like, I've adapted to not hearing it, but if I. Every. Probably few times a week, I'll be in a really quiet space and realize that I have constant ringing. Have you looked into hearing aids? No. Yeah. Maybe I should. Yeah. So I just got the Oticon Intense. Yeah. Okay. That increases your. You're not wearing them right now. Not right now. Yeah. But you've. You've been testing them out. Yeah, exactly. I actually. I'm so sad. I was running out the door and I forgot them. Yeah. I just finished my morning routine, so. I'm still sad. But. Yeah, but they actually, I've only had them for a week. They have substantially improved my life. Wow. Yeah. Cool. Well, this conversation has substantially improved my. Yeah, you guys, this is fun. This is great. Yeah. This is fantastic. Congratulations, and we will talk back again soon. We have our next guest in the restream waiting room. But first, let me tell you about profound. Get your brand mentioned in chatgpt restaurant.